Phase I Dose‐escalation Study of Venetoclax Plus Beam Followed by Autologous Stem Cell Transplant (asct) for Chemoresistant, Relapsed/refractory, or High‐risk Non‐hodgkin's Lymphoma (nhl); Preliminary Results
Year: 2019
Type: article
Source: Hematological Oncology
DOI: 10.1002/hon.213_2631
Authors: J. Maakaron, Q. Zhao, M. Puto, R. Von Derau, J. Robinson, J. Brammer, S. Penza, R. Baiocchi, B. Christian, K. Maddocks, A. Saad, S. Wall, D. Benson, Y. Efebera, A. Rosko, S. Ayyappan, N. Grieselhuber, S. Vasu, K. Larkin, N. Epperla, S. Devarakonda, H. Choe, M. Chaudhry, B. Blaser, J. Blachly, B. Bhatnagar, L. Alinari, A. Mims, S. Jaglowski, B.M. William
Institution: The Ohio State University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2951228396